TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21899919

Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03%
Number of subjects: 278

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 278
Study: 20015727

Group type: EXPERIMENTAL
Intervention: Lidocaine spray 10%
Number of subjects: 48

Group type: COMPARATOR
Intervention: Tetracaine 2% solution
Number of subjects: 48
Study: 18457617

Group type: EXPERIMENTAL
Intervention: Intensive preventive program (quarterly examinations by general practitioner, treatment adjustments, lifestyle reinforcement)
Number of subjects: 983

Group type: EXPERIMENTAL
Intervention: Intensive preventive program
Number of subjects: 983
Study: 16154702

Group type: EXPERIMENTAL
Intervention: RDC/TMD diagnoses of myofascial pain with limited opening
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: RDC/TMD diagnoses of myofascial pain without limited opening
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: RDC/TMD diagnoses of arthralgia
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: RDC/TMD diagnoses of disc displacement with reduction
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: RDC/TMD diagnoses of disc displacement without reduction, osteoarthritis, and osteoarthrosis
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Grouped diagnoses into pain versus non-pain
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Detecting any diagnosis versus no diagnosis
Number of subjects: 230
Study: 12437643

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Normal HGF values (< 1.7 ng/ml, n = 69)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Elevated HGF (≥ 1.7 ng/ml, n = 26)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Healthy controls (n = 62)
Number of subjects: 128
Study: 10599590

Group type: EXPERIMENTAL
Intervention: Biniwas (2 x 550 mg/day) for six months
Number of subjects: 30
Study: 7861247

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (60 mg every 4 months; 30 mg for infants 6-11 months)
Number of subjects: 592

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 592
Study: 2166377

Group type: EXPERIMENTAL
Intervention: 20 mg enoxaparin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 40 mg enoxaparin
Number of subjects: 20
Study: 6178567

Group type: EXPERIMENTAL
Intervention: Methisoprinol (4 g/day per os in 4 divided doses for 2 weeks)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63

Group type: COMPARATOR
Intervention: Normo- or hypo-ergic patients (not treated with methysoprinol or placebo)
Number of subjects: 63
Study: 30448878

Group type: EXPERIMENTAL
Intervention: Dark roast coffee blend (500 ml per day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Water (500 ml per day)
Number of subjects: 100
Study: 29284402

Group type: EXPERIMENTAL
Intervention: Personal activity tracker (Fitbit Charge 2)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard post hospital care
Number of subjects: 200
Study: 26351838

Group type: EXPERIMENTAL
Intervention: myosignal feedback on a computer screen
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: virtual myoelectric prosthetic hand
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: computer game
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Training (all methods)
Number of subjects: 36
Study: 24550191

Group type: EXPERIMENTAL
Intervention: Saturated fatty acids (SFAs) overfeeding (palm oil)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Polyunsaturated fatty acids (PUFAs) overfeeding (sunflower oil)
Number of subjects: 39
Study: 22975068

Group type: EXPERIMENTAL
Intervention: Ghrelin synthesis administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ghrelin replacement therapy during chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ghrelin administration for controlling postoperative cytokine storm
Number of subjects: 0
Study: 19414681

Group type: EXPERIMENTAL
Intervention: Combination of all‐trans retinoic acid (ATRA) and chemotherapy, maintenance treatment, escalating doses of cytarabine, early administration of dexamethasone, and CNS prophylaxis.
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Enrollment onto the APL 2000 trial and combined maintenance with ATRA and chemotherapy.
Number of subjects: 902

Group type: COMPARATOR
Intervention: APL 93 trial (previous standard treatment).
Number of subjects: 902
Study: 17615472

Group type: EXPERIMENTAL
Intervention: Insight-oriented nursing program
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study: 15714899

Group type: EXPERIMENTAL
Intervention: Verbal short-term memory task using concrete and abstract words
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Verbal short-term memory task using phonologically similar and dissimilar words
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group matched on digit span
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group matched on vocabulary level
Number of subjects: 14
Study: 12069980

Group type: EXPERIMENTAL
Intervention: 5% acyclovir cream
Number of subjects: 1385

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 1385
Study: 10402283

Group type: EXPERIMENTAL
Intervention: Mechanical compression device (FemoStop) with ultrasound guidance (G1)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Mechanical compression device (FemoStop) without ultrasound guidance (G2)
Number of subjects: 38
Study: 7594328

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg daily for 8 weeks
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Clarithromycin 200 mg twice daily for 2 weeks and Lansoprazole 30 mg daily for 8 weeks
Number of subjects: 39
Study: 1974743

Group type: EXPERIMENTAL
Intervention: Continuous medication
Number of subjects: 116

Group type: COMPARATOR
Intervention: Targeted medication
Number of subjects: 116
Study: 497077

Group type: EXPERIMENTAL
Intervention: Pancuronium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcuronium
Number of subjects: 0
Study: 31069957

Group type: EXPERIMENTAL
Intervention: Vaginal film
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Vaginal ring
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Vaginal insert (tablet)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Vaginal gel
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: On-demand products (film, insert, gel)
Number of subjects: 200
Study: 28716786

Group type: EXPERIMENTAL
Intervention: Online pulmonary rehabilitation (my-PR)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Face-to-face pulmonary rehabilitation
Number of subjects: 90
Study: 26372485

Group type: EXPERIMENTAL
Intervention: NVP-NVP (maternal intrapartum sdNVP with a 7-day 'tail' of ZDV along with lamivudine, and infant NVP)
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Infant-only NVP (maternal placebos for sdNVP and the 'tail', with infant NVP)
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: LPV/r (maternal LPV/r starting at 28 weeks)
Number of subjects: 435
Study: 23388445

Group type: EXPERIMENTAL
Intervention: Conditioned media from human amniotic epithelial cells (CM from HAECs)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Vehicle alone
Number of subjects: 18

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 18
Study: 21470913

Group type: EXPERIMENTAL
Intervention: Exercise intervention (endurance exercise and resistance training)
Number of subjects: 60
Study: 19967619

Group type: EXPERIMENTAL
Intervention: Pico-Salax (sodium picosulphate with magnesium citrate), administered in two doses: one the evening before and one on the morning of the procedure
Number of subjects: 83

Group type: COMPARATOR
Intervention: PEG‐ELS (polyethylene glycol with electrolyte solution), administered over 4 hours
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Pico-Salax
Number of subjects: 83

Group type: COMPARATOR
Intervention: PEG‐ELS
Number of subjects: 83
Study: 17432395

Group type: COMPARATOR
Intervention: C‐SE non‐etch
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: C‐SE etch
Number of subjects: 29
Study: 15077265

Group type: EXPERIMENTAL
Intervention: Prednisone (10 mg/day)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 11473861

Group type: EXPERIMENTAL
Intervention: remifentanil 0.25 microg/kg (Group R1)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: remifentanil 0.5 microg/kg (Group R2)
Number of subjects: 120

Group type: COMPARATOR
Intervention: normal saline (Group P)
Number of subjects: 120
Study: 9596201

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8001300

Group type: EXPERIMENTAL
Intervention: K-strophanthin (0.125 mg intravenously)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Digoxin (0.25 mg orally)
Number of subjects: 22
Study: 2968749

Group type: EXPERIMENTAL
Intervention: Prednisolone sodium tetrahydrophthalate followed by oral prednisone for 2 days
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Aldosterone followed by oral 9 alpha fludrocortisone for 2 days
Number of subjects: 9
Study: 31904685

Group type: EXPERIMENTAL
Intervention: Esophageal stimulation via an esophageal stimulating catheter (E‐Motion Tube)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 155
Study: 31568669

Group type: EXPERIMENTAL
Intervention: Online support forum participation
Number of subjects: 258
Study: 27146798

Group type: EXPERIMENTAL
Intervention: Music Therapy (MT)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard supportive treatment (Control Group)
Number of subjects: 66
Study: 25060288

Group type: EXPERIMENTAL
Intervention: Tailored-print intervention (three computer-tailored newsletters)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Control (pamphlet detailing public health recommendations for physical activity)
Number of subjects: 330
Study: 24266309

Group type: EXPERIMENTAL
Intervention: Endoscopic hemoclips therapy (group I)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Combination therapy of hemoclips and epinephrine (group II)
Number of subjects: 70
Study: 21531453

Group type: EXPERIMENTAL
Intervention: ZrO(2), modified via novel 3.2 nm silica layer/silane‐treated
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ZrO(2), modified via novel 5.8 nm silica layer/silane‐treated
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ZrO(2), modified via novel 30.4 nm silica layer/silane‐treated
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: HF‐etched/silane‐treated ZrO(2)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Primer‐treated ZrO(2)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Porcelain (control)
Number of subjects: 12
Study: 18695787

Group type: EXPERIMENTAL
Intervention: Multimedia educational computer program
Number of subjects: 35

Group type: COMPARATOR
Intervention: Traditional theoretical class
Number of subjects: 35
Study: 16449027

Group type: EXPERIMENTAL
Intervention: rhIGF-I at 80 microg/kg body weight daily (n = 6)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: rhIGF-I at 40 microg/kg twice daily (n = 6)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: rhIGF-I at 80 microg/kg twice daily (n = 6)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 18
Study: 12566183

Group type: EXPERIMENTAL
Intervention: Ambulatory epidural analgesia (intermittent epidural injections of 0.1% ropivacaine with 0.6 microg/ml sufentanil)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Non-ambulatory epidural analgesia (intermittent epidural injections of 0.1% ropivacaine with 0.6 microg/ml sufentanil)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Ambulatory epidural analgesia
Number of subjects: 221

Group type: COMPARATOR
Intervention: Non-ambulatory epidural analgesia
Number of subjects: 221
Study: 10693153

Group type: EXPERIMENTAL
Intervention: 60 mg of d,l‐fenfluramine (intervention group: bulimia nervosa remitted)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (control group: healthy controls)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 60 mg of d,l‐fenfluramine (intervention group: current bulimia nervosa)
Number of subjects: 21
Study: 9497949

Group type: EXPERIMENTAL
Intervention: Audit intervention in one hospital
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Audit intervention focusing on three target objectives
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control hospitals (no audit intervention)
Number of subjects: 0
Study: 10412478

Group type: EXPERIMENTAL
Intervention: Extensive Amalgam Restorations (EAR) with five different auxiliary retention methods.
Number of subjects: 300
Study: 3518980

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg sublingual)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 31403695

Group type: EXPERIMENTAL
Intervention: E-liquids with PG/VG ratio 70/30
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: E-liquids with PG/VG ratio 50/50
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: E-liquids with PG/VG ratio 0/100
Number of subjects: 30
Study: 30535217

Group type: EXPERIMENTAL
Intervention: 0.5 μg of oral alfacalcidol per day (intervention group; n=495)
Number of subjects: 976

Group type: COMPARATOR
Intervention: Treatment without vitamin D receptor activators (control group; n=481)
Number of subjects: 976
Study: 26995361

Group type: EXPERIMENTAL
Intervention: Illness Management and Recovery (IMR)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 200
Study: 26467790

Group type: EXPERIMENTAL
Intervention: 650 mg acetaminophen
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: 400 mg ibuprofen
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: 7.5 mg meloxicam
Number of subjects: 321
Study: 23648081

Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil 50 mg (group FT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (group CP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (group CT)
Number of subjects: 80
Study: 20959485

Group type: EXPERIMENTAL
Intervention: Hierarchical clustering of HPV genotype patterns
Number of subjects: 2780

Group type: EXPERIMENTAL
Intervention: Cluster 1 (CIN3 histology with abnormal cytology)
Number of subjects: 2780

Group type: EXPERIMENTAL
Intervention: Cluster 2 (CIN3 histology with normal cytology)
Number of subjects: 2780

Group type: EXPERIMENTAL
Intervention: Cluster 3 (Older women with normal/low-grade histology)
Number of subjects: 2780

Group type: EXPERIMENTAL
Intervention: Cluster 4 (Younger women with low-grade histology)
Number of subjects: 2780

Group type: EXPERIMENTAL
Intervention: HPV genotype group 1
Number of subjects: 2780

Group type: EXPERIMENTAL
Intervention: HPV genotype group 2
Number of subjects: 2780

Group type: EXPERIMENTAL
Intervention: HPV genotype group 3
Number of subjects: 2780

Group type: COMPARATOR
Intervention: Colposcopy
Number of subjects: 2780
Study: 18990046

Group type: EXPERIMENTAL
Intervention: 2 weeks of 2 different chiropractic techniques
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: 6 weeks of 2 different chiropractic techniques
Number of subjects: 432

Group type: COMPARATOR
Intervention: Medical care consisting of 3 provider visits for medications
Number of subjects: 432

Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 432
Study: 16906017

Group type: EXPERIMENTAL
Intervention: Alfentanil at concentrations of 0, 33.33, 66.67, and 100 ng/ml
Number of subjects: 20
Study: 14516427

Group type: EXPERIMENTAL
Intervention: Combined surgery group (360 degrees scleral buckling, pars plana vitrectomy, air-fluid exchange, endolaser, injection of 14% perfluoropropane gas)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Scleral buckling group (360 degrees scleral buckling, cryopexy, external subretinal fluid drainage)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Combined surgery group
Number of subjects: 44

Group type: COMPARATOR
Intervention: Scleral buckling group
Number of subjects: 44
Study: 10905242

Group type: EXPERIMENTAL
Intervention: Regular inhaled salbutamol 400 microg four times daily for 12 months
Number of subjects: 983

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 983

Group type: EXPERIMENTAL
Intervention: Regular inhaled salbutamol 400 microg four times daily
Number of subjects: 983
Study: 9216092

Group type: EXPERIMENTAL
Intervention: TT5 (5 days treatment with furazolidone 600 mg/day, metronidazole 750 mg/day, amoxicillin 1.5 g/day)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: TT10 (10 days treatment with furazolidone 600 mg/day, metronidazole 750 mg/day, amoxicillin 1.5 g/day)
Number of subjects: 54

Group type: COMPARATOR
Intervention: All patients (combined analysis)
Number of subjects: 54
Study: 1596304

Group type: EXPERIMENTAL
Intervention: Simvastatin with a low fat diet
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Simvastatin with a high fat diet
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 19
Study: 6712199

Group type: EXPERIMENTAL
Intervention: Mezlocillin, 4 g every 6 h
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Carbenicillin, 7.5 g every 6 h
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo, 0.9% NaCl, 50 ml every 6 h
Number of subjects: 18
Study: 31672143

Group type: EXPERIMENTAL
Intervention: enteral Levetiracetam (eLVT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: phenobarbital
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: eLVT
Number of subjects: 30
Study: 27989864

Group type: EXPERIMENTAL
Intervention: Fluorescence visualization by inexperienced examiner
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fluorescence visualization by expert professional
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional white light examination by inexperienced examiner
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional white light examination by expert professional
Number of subjects: 15
Study: 25661298

Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 6103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6103
Study: 23982113

Group type: EXPERIMENTAL
Intervention: Omega-3 (1.8 g daily for 12 weeks)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Omega-3
Number of subjects: 355
Study: 22851558

Group type: EXPERIMENTAL
Intervention: RT + PCV
Number of subjects: 251

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 251
Study: 19683191

Group type: EXPERIMENTAL
Intervention: Betaxolol 0.25% (twice daily)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: TGFS 0.25% (daily)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: TGFS 0.5% (daily)
Number of subjects: 105
Study: 17532892

Group type: EXPERIMENTAL
Intervention: Modified 30-item assessment (after removal of reflex items)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Rasch item-fit statistics
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Rasch-generated item-difficulty order
Number of subjects: 512
Study: 15887019

Group type: EXPERIMENTAL
Intervention: Nationwide interdisciplinary preventive programme targeting reduction of exposure to powdered high-protein latex gloves.
Number of subjects: 884
Study: 15920212

Group type: EXPERIMENTAL
Intervention: HES 130/0.4 (6%)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: HES 200/0.5 (6%)
Number of subjects: 31
Study: 10589178

Group type: EXPERIMENTAL
Intervention: Endovascular stent-graft repair
Number of subjects: 150
Study: 8913399

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 500 mg in 2 mL of lidocaine 1% solution (250 mg/mL)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 500 mg in 1.4 mL of lidocaine 1% solution (350 mg/mL)
Number of subjects: 17
Study: 1862788

Group type: EXPERIMENTAL
Intervention: 200 mg/day desipramine
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 400 mg/day amantadine-placebo
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 6614521

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine-HCl (n = 10)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine-CO2 (n = 10)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 1.0% etidocaine (n = 10)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 1.5% etidocaine (n = 10)
Number of subjects: 40
Study: 30933317

Group type: EXPERIMENTAL
Intervention: Yoga during treatment
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Yoga post-treatment
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Yoga (mixed samples)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 29
Study: 29396788

Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 27545747

Group type: EXPERIMENTAL
Intervention: Integrated Approach of Yoga Therapy (IAYT)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (waitlist)
Number of subjects: 81
Study: 24588893

Group type: EXPERIMENTAL
Intervention: mHealth comprehensive cardiac rehabilitation program (24-week personalized text message program and access to a supporting website)
Number of subjects: 120

Group type: COMPARATOR
Intervention: usual cardiac rehabilitation care
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: mHealth comprehensive cardiac rehabilitation program
Number of subjects: 120
Study: 22998339

Group type: EXPERIMENTAL
Intervention: Experimental group (noncaloric beverages provided at home for 1 year)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Experimental group (Hispanic participants)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 224
Study: 19879305

Group type: EXPERIMENTAL
Intervention: Schizophrenia participants during VOT-based discrimination in noise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy comparison subjects during VOT-based discrimination in noise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Schizophrenia participants and healthy comparison subjects during first syllable discrimination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Schizophrenia participants during POA-based discrimination in noise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Schizophrenia participants and healthy comparison subjects
Number of subjects: 0
Study: 17566756

Group type: EXPERIMENTAL
Intervention: 830nm LED phototherapy
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: 633nm LED phototherapy
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Combination of 830 and 633nm LED phototherapy
Number of subjects: 76

Group type: COMPARATOR
Intervention: Sham treatment light
Number of subjects: 76